ArticleOncology letters2017

Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons.

Mitsunori Higuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.